Leerink Partnrs Estimates AnaptysBio FY2029 Earnings
AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Leerink Partnrs issued their FY2029 earnings per share (EPS) estimates for shares of AnaptysBio in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst D. Risinger anticipates that the biotechnology company will earn ($2.28) per share for the year. The consensus estimate […]
